Close Window

Digital Look Email A Friend

TheraCryf signs deal for Ox-1 addiction treatment development

Published by Josh White on 12th May 2025

(Sharecast News) - TheraCryf announced on Monday that it has entered into a master service agreement with contract research organisation Pharmaron UK to support the development of its Orexin-1 addiction treatment programme.

URL: http://www.digitallook.com/dl/news/story/35073108/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.